ClinVar Miner

Submissions for variant NM_001145809.2(MYH14):c.1625T>G (p.Leu542Arg)

dbSNP: rs727504564
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000155729 SCV000205439 likely benign not specified 2013-05-03 criteria provided, single submitter clinical testing Leu542Arg in exon 14 of MYH14: This variant has not been previously reported in individuals affected with hearing loss or in large population studies. Computati onal analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyP hen2, and SIFT) suggest that the Leu542Arg variant may impact the protein, thoug h this information is not predictive enough to determine pathogenicity. However , although this variant was identified in an individual with hearing loss, it di d not segregate with hearing loss in an affected family member and was detected in two unaffected family members; this evidence supports a more likely benign ro le for this variant. In summary, this variant is likely benign based on the seg regation analysis in this family and therefore it is unlikely to be responsible for the hearing loss in affected family members.
CeGaT Center for Human Genetics Tuebingen RCV002262758 SCV002543965 uncertain significance not provided 2022-04-01 criteria provided, single submitter clinical testing MYH14: PM2, PP3

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.